Open AccessDrug-Induced Liver Injury Network (DILIN) Prospective Study
Author(s) -
Robert J. Fontana,
Paul B. Watkins,
Herbert L. Bonkovsky,
Naga Chalasani,
Timothy J. Davern,
José Serrano,
James Rochon
Publication year - 2009
Publication title -
drug safety
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.377
H-Index - 124
eISSN - 1179-1942
pISSN - 0114-5916
DOI - 10.2165/00002018-200932010-00005
Subject(s) - medicine , prospective cohort study , liver injury , medical prescription , pharmacovigilance , adverse effect , intensive care medicine , pharmacology
Drug-induced liver injury (DILI) is an uncommon adverse drug reaction of increasing importance to the medical community, pharmaceutical industry, regulatory agencies and the general public.